Additionally, several studies have shown improvements in cardiac function after MI either by endogenous bone marrow [5] or by augmenting this endogenous MSC response via injection of Granulocyte-macrophage colony-stimulating factor (GM-CSF) and other stem cell-mobilizing factors [6]. This evidence concerns the gene CSF2 and myocardial infarction.